Please join us in congratulating Nishant Agrawal, MD, as he begins his new role as the inaugural Chair of the University of Chicago’s new Department of Otolaryngology-Head and Neck Surgery. https://ow.ly/KC6650Zuxz2

WEBINAR: Cancer Care Reimagined: Inside UChicago Medicine’s New AbbVie Foundation Cancer Pavilion Featuring Dr. Kunle Odunsi, Kimyatta Washington, & Dr. Nita Lee Date: Wed, 8/12 Time: 12:00-1:00 PM CT RSVP: qrco.de/cancerpavili... #AbbVieFoundationCancerPavilion #UChicagoMedicine

We're proud to be part of this weekend's Black Women's Expo in Chicago. Visit our booth to meet with us and learn about cancer screening and prevention.

New podcast episode just dropped 💥: Learn how AI and machine learning are transforming cancer research and care. https://ow.ly/Ee6i50Zuqs9

How Do I Know if a Clinical Trial Is Right for Me? A comic explaining the risks and benefits of participating in a cancer clinical trial, translated for a Polish-speaking audience.

Zhang et al., published a new article in #JCOPrecisionOncology highlighting the potential of cfDNA-derived 5-hydroxymethycytosine signatures as a noninvasive prognostic biomarker in newly diagnosed multiple myeloma. @uchicagomedicine.bsky.social https://ow.ly/4ekN50ZtAg9

🔥Hot off the press: The University of Chicago researchers show reduced pancreatic tumor growth using engineered Bifidobacterium to produce super mutant IL-2 that activates tumor-fighting T cells. UChicago Pritzker Molecular Engineering https://ow.ly/9cvS50Zs61j

Dr. Peter O'Donnell is quoted in this SurvivorNet story about a newly approved bladder cancer treatment. www.survivornet.com/articles/new...

New Approval Means More Bladder Cancer Patients Can Access Powerful Immunotherapy Combination: What To Know About Keytruda + Padcev

A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, offering a more effective option for many patients.

survivornet.com

Drs. Ackroyd & Lee recently published in the International Journal of Gynecologic Cancer, highlighting the importance of shared decision-making and patient-centered care in advanced and recurrent uterine cancer. Read ➡️ bit.ly/3T0nLwd @uchicagocancer.bsky.social

Dr. Mark Ratain offers perspective on the recent retraction of a @NatureMedicine paper, underscoring the importance of data integrity, rigorous clinical trial design, and transparency in advancing cancer research and patient care. @uchicagomedicine.bsky.social https://ow.ly/EIjj50ZnVLZ

In the latest episode of BackTable Tumor Board, Drs. Chih-Yi Liao and Xavier Keutgen discuss the key steps involved in the diagnosis and management of neuroendocrine tumors, from staging and imaging to treatment decisions. @uchicagomedicine.bsky.social https://ow.ly/6O3e50Zntax

Singh et al. published a new study in NPJ Precision Oncology identifying progressive transcriptional reprogramming as a driver of the malignant transformation of IP-SNSCC. @uchicagomedicine.bsky.social Nature Portfolio https://www.nature.com/articles/s41698-026-01599-4

Helping cancer patients quit smoking has been sidelined for too long. No Smoker Left Behind Initiative led by Dr. Andrea King shows proactive, evidence-based cessation care can reach diverse cancer populations and work in real-world settings. Healio https://ow.ly/JSrn50Zm3L7

Recently the FDA approved the combination of belzutifan and pembrolizumab as an adjuvant treatment for adults with clear cell renal cell carcinoma who are at an intermediate-high or high risk of recurrence after surgery. https://www.survivornet.com/articles/v/

Rita Nanda, MD, said the FDA approval of sacituzumab-based therapy for the first-line treatment of metastatic TNBC gives patients and their care teams an important new option at the very beginning of their treatment journey. https://ow.ly/Z4UQ50ZlKQv

Bone and soft tissue cancer can be frightening for children and adults. However, the latest treatments available at UChicago Medicine — from innovative chemotherapy to limb-sparing surgery — can reduce pain, fight the disease and preserve the ability to walk, work or play. https://ow.ly/Rc6A50Zlf3k

Kudos to Benjamin Shogan, MD, and colleagues on publishing a new study in Nature Communications, demonstrating antimicrobial resistance and collagen producing bacteria as a prognostic biomarker for postoperative oncologic outcomes in colorectal cancer recurrence. https://ow.ly/mlAQ50ZlcGU

Congratulations to Kathryn Mills, MD, and Milica Medved, PhD, for being awarded a Team Science grant from the Gray Foundation for projects applying the newest advances in technology and AI to the biggest questions in the BRCA-associated cancer field. www.businesswire.com/news/home/20...

Happy Fourth of July from the UChicago Medicine Comprehensive Cancer Center! Today, we celebrate independence, resilience and community while honoring the patients, families, caregivers, researchers and care teams who inspire us every day. Wishing everyone a safe holiday!

Join us in congratulating Scott Oakes, MD, who has been named the first Frank W. Fitch Professor in the Department of Pathology. Dr. Scott's work has advanced understanding of stress-signaling pathways in cancer, diabetes and other diseases. University of Chicago Pathology https://ow.ly/JFak50ZjG37

In a new study, Jeff Rathmell, PhD, and colleagues demonstrate that MMP is increased in exhausted T cells, suggesting MMP may serve as a biomarker for monitoring responses to immunotherapy treatment. The Journal of Immunology https://ow.ly/yUbl50ZigXB

We are so excited for graduating Fellow Dr. Peiffer who recently won a @susangkomen.bsky.social Career Transition Award to support his future research in the labs of Drs. @ritanandamd.bsky.social and Greene! Read more about his research at www.komen.org/blog/komens-... Congratulations!!!

Komen’s Investment in the Future of Breast Cancer Research

Komen is investing in the future of breast cancer research, awarding $15.4 million to researchers working on accelerating breakthroughs.

komen.org

Jung Woo Kwon, MD, and colleagues published a new study showing that a subset of usual-type penile squamous cell carcinoma (pSCC) are positive for HPV, suggesting routine HPV testing in all pSCCs with the usual-type morphology. https://ow.ly/M08a50ZhfwH

Hurdles in the Fight Against De Novo Metastatic Breast Cancer www.medpagetoday.com/resource-cen...

Hurdles in the Fight Against De Novo Metastatic Breast Cancer - Advanced and Metastatic Breast Cancer: A Peer-to-Peer View

According to a team of investigators at the University of Chicago, patients with de novo metastatic breast cancer (dnMBC) encounter racial and ethnic disparities in disease presentation, in addition t...

medpagetoday.com

A clinical trial helped Sonya Alexander find relief from joint pain after breast cancer treatment. https://www.uchicagomedicine.org/forefront/health-and-wellness-articles/clinical-trials-in-the-southland

Clinical trials in the Southland: Ingalls Memorial patients can join UChicago Medicine efforts - UChicago Medicine

Southland residents can access leading clinical trials through UChicago Medicine Ingalls Memorial and UChicago Medicine Medical Center in Hyde Park, offering new hope and treatment options close to home.

uchicagomedicine.org

Today, the AACR released its Cancer Disparities Progress Report, a comprehensive analysis of the unequal burden of cancer in the US. The report highlights both the progress made and the persistent disparities affecting medically underserved populations. www.CancerDisparitiesProgressReport.org

In our latest podcast episode, two prominent cancer leaders, Dr. Soni Smith and Dr. Kay Macleod discuss how strong, collaborative leadership at UChicago is driving innovation and shaping the future of cancer research and patient care. https://ow.ly/ML0B50Zg0wQ

New research in JAMA Oncology from the WISDOM Study highlights the importance of population-based pathogenic variant testing in risk-based breast cancer screening. #PolygenicRiskScores #BreastCancerRisk @uchicagoobgyn.bsky.social @uchicagomedicine.bsky.social https://ow.ly/aRAO50Zfpmk

The new AbbVie Foundation Cancer Pavilion, Illinois’ first freestanding cancer care facility, is set to open in April 2027. Construction crew members reflect on the meaningful connection they’ve built while bringing this purpose-driven facility to life. https://ow.ly/c4It50ZecKt

🔥Hot off the press: Sun et al. published a new study in JAMA Network Open reporting a 162-variant TNBC PRS that showed the best discrimination and offers a promising, more equitable approach to genetic testing for women of African ancestry. @uchicagomedicine.bsky.social https://ow.ly/lKA950ZcQcJ